Treatment Guidelines from The Medical Letter
FROM
ISSUE
135
Drugs for Parkinson's Disease
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Levodopa combined with carbidopa is still the most effective treatment for symptoms of Parkinson's disease. Dopamine agonists, the next most effective class of drugs, can be used alone before the introduction of levodopa or as an adjunct to levodopa. Addition of a peripherally-acting COMT inhibitor or an MAO-B inhibitor to levodopa can reduce motor fluctuations in patients with advanced disease. Amantadine may have mild symptomatic benefit and can decrease levodopa-induced dyskinesias. Anticholinergics are rarely used because of their adverse effects, but can be a useful addition to levodopa for control of tremor and drooling. Subcutaneous apomorphine should be available for rescue use in patients with "off" episodes. Deep brain stimulation is an option for patients with levodopa-induced motor complications and relatively intact cognition.

The motor symptoms of Parkinson's disease (PD) are caused primarily by progressive degeneration ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Parkinson's Disease
Article code: 135a
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian